We are live on ! Find out more
KURA icon

Kura Oncology

134 hedge funds and large institutions have $856M invested in Kura Oncology in 2020 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 58 increasing their positions, 35 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

373% more call options, than puts

Call options by funds: $4.07M | Put options by funds: $859K

103% more capital invested

Capital invested by funds: $421M → $856M (+$435M)

94% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 16

66% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 35

50% more funds holding in top 10

Funds holding in top 10: 46 (+2)

13% more funds holding

Funds holding: 119134 (+15)

2.74% more ownership

Funds ownership: 93.43%96.16% (+2.7%)

Holders
134
Holders Change
+15
Holders Change %
+12.61%
% of All Funds
2.75%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.12%
New
31
Increased
58
Reduced
35
Closed
16
Calls
$4.07M
Puts
$859K
Net Calls
+$3.21M
Net Calls Change
+$3.32M
Name Holding Trade Value Shares
Change
Change in
Stake
UBS Group
126
UBS Group
Switzerland
$4K -$235K -16,301 -98%
Daiwa Securities Group
127
Daiwa Securities Group
Japan
$3K
LC
128
Lindbrook Capital
California
$2K
PA
129
Parallel Advisors
California
$2K +$1.98K +137 New
BCA
130
Berman Capital Advisors
Georgia
$2K +$2.27K +157 New
Royal Bank of Canada
131
Royal Bank of Canada
Ontario, Canada
$1K -$1.31K -91 -63%
AssetMark Inc
132
AssetMark Inc
California
$1K -$274 -19 -38%
IFAM
133
Institutional & Family Asset Management
Colorado
$1K -$202 -14 -23%
JCM
134
Jacobi Capital Management
Pennsylvania
$1K
Brown Advisory
135
Brown Advisory
Maryland
-$6.25M -627,667 Closed
GPP
136
Great Point Partners
Connecticut
-$1.79M -179,700 Closed
Renaissance Technologies
137
Renaissance Technologies
New York
-$848K -85,271 Closed
BG
138
Bellevue Group
Switzerland
-$568K -57,100 Closed
Allianz Asset Management
139
Allianz Asset Management
Germany
-$522K -52,493 Closed
SIM
140
Spark Investment Management
New York
-$471K -47,363 Closed
DCM
141
Driehaus Capital Management
Illinois
-$299K -30,000 Closed
EMG
142
Ellington Management Group
Connecticut
-$270K -27,100 Closed
Prudential Financial
143
Prudential Financial
New Jersey
-$176K -17,694 Closed
Jacobs Levy Equity Management
144
Jacobs Levy Equity Management
New Jersey
-$175K -17,602 Closed
Acadian Asset Management
145
Acadian Asset Management
Massachusetts
-$77K -7,693 Closed
Ensign Peak Advisors
146
Ensign Peak Advisors
Utah
-$66K -6,647 Closed
AIM
147
Aigen Investment Management
New York
-$64K -6,403 Closed
MOACM
148
Mutual of America Capital Management
New York
-$20K -2,000 Closed
CG
149
Cutler Group
California
-$5K -600 Closed

KURA Hedge Fund Activity: Q2 2020 in Review

134 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q2 2020, worth a combined $856M — up 103% from $421M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new KURA positions and 16 closed out — a net gain of 15 holders — while 58 added to existing stakes and 35 trimmed.

The largest buyer was BlackRock, adding an estimated $20M. The largest seller was Victory Capital Management, cutting an estimated $46.1M.

  • 134 institutional investors held Kura Oncology (KURA) as of Q2 2020, up from 119 in Q1 2020.
  • Funds reported $856M of Kura Oncology stock for Q2 2020, up 103% quarter-over-quarter.
  • 31 funds opened new Kura Oncology positions in Q2 2020 and 16 closed out, a net change of +15 holders.
  • The largest Kura Oncology buyer in Q2 2020 was BlackRock, an estimated $20M added.
  • The largest Kura Oncology seller in Q2 2020 was Victory Capital Management, an estimated $46.1M sold.

Based on aggregated 13F filings for Q2 2020.